Monthly information related to total number of voting rights and shares composing the share capital – January 31, 2022
Monthly Voting Rights Report: As of January 31, 2022, the total number of shares for Erytech Pharma is 31,018,553, with 32,518,339 gross voting rights and 32,515,839 net voting rights. This aligns with December figures, indicating stability in share composition and voting rights. The report was issued under article 223-16 of the French AMF regulations, serving shareholders and investors with essential compliance data on voting power.
- None.
- None.
Monthly information related to total number of voting rights and shares composing the share capital – January 31, 2022.
Article 223-16 of general regulation of French Autorité des Marchés Financiers
Lyon – France
Listing markets:
Euronext Paris from Euronext (Market segment C - ISIN Code: FR0011471135- Symbol: ERYP) &
Nasdaq Global Select Market in the United-States (Symbol : ERYP)
Website : www.erytech.com
| Date | Total of shares composing the share capital | Total of brut (1) voting rights | Total of net (2) voting rights |
| December 31, 2021 | 31 018 553 | 32 518 339 | 32 515 839 |
| January 31, 2022 | 31 018 553 | 32 518 339 | 32 515 839 |
(1) Gross voting rights number (or « theoretical » voting rights) is used as a basis for calculating the crossing of the threshold. In accordance with article 223-11 of general regulation of Autorité des Marchés Financiers, this number is calculated on the basis of all shares carrying the single and double voting rights, including shares without voting rights.
(2) Without treasury shares.
Attachment
FAQ
What is the total number of shares for ERPY as of January 31, 2022?
How many gross voting rights does ERPY have as of January 31, 2022?
What are the net voting rights for ERPY as of January 31, 2022?
How does the voting rights report affect ERPY shareholders?
